Compare Pfizer Inc (PFE) vs Western Union Co (WU) Price & Performance

Pfizer (PFE) trades at $24.75, down 1.2% on the day, with a neutral technical outlook. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $0.75 beating expectations of $0.722. Pfizer demonstrates robust profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated from pandemic peaks. Recent news highlights the company's focus on AI drug discovery and pipeline development.

Pfizer presents a value opportunity trading below analyst consensus target of $28.25, with 38% of analysts rating it Buy. The stock offers a solid dividend yield with recent $0.43 payments. Key risks include patent expirations and revenue normalization post-COVID, while catalysts include obesity and oncology pipeline developments in 2026.

Western Union (WU) trades at $8.46, down 4.73% on the day, with a bullish technical signal but mixed sentiment. The stock shows attractive valuation metrics with a P/E of 6.37 and P/S of 0.69, supported by strong profitability including a 10.88% net margin and 47.66% ROE. Recent developments include a partnership with Total Wireless and pending acquisition of Intermex, while Q1 2026 earnings missed expectations. Cash flow trends show volatility, with 2025 net cash flow negative $469.2 million.

Outlook remains cautious due to declining revenue trends and mixed analyst ratings, with 58% hold recommendations. The 11% dividend yield offers income appeal, but competitive pressures and execution risks on digital transformation pose challenges. Near-term catalyst is Q2 2026 results on July 30, 2026, with consensus EPS estimate of $0.43.